Ticker Details
Pacific Biosciences of California, Inc. Pacific Biosciences of California Inc is a biotechnology company. It is engaged in design, development, and manufacture of sequencing system to help scientists resolve genetically complex problems.
IPO Date:	October 27, 2010
Sector:	Healthcare
Industry:	Medical Diagnostics and Research
Market Cap:	$486.07M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.24 | 3.26%
Avg Daily Range (30 D):	$0.09 | 4.28%
Avg Daily Range (90 D):	$0.09 | 4.47%

Institutional Daily Volume
Avg Daily Volume:	2.76M
Avg Daily Volume (30 D):	7.52M
Avg Daily Volume (90 D):	8.13M

Trade Size
Avg Trade Size (Sh.):	202
Avg Trade Size (Sh.) (30 D):	388
Avg Trade Size (Sh.) (90 D):	423

Institutional Trades
Total Institutional Trades:	4,408
Avg Institutional Trade:	$2.16M
Avg Institutional Trade (30 D):	$.93M
Avg Institutional Trade (90 D):	$.85M
Avg Institutional Trade Volume:	.23M
Avg Institutional Trades (Per Day):	2

Market Closing Trades
Avg Closing Trade:	$3.28M
Avg Closing Trade (30 D):	$.97M
Avg Closing Trade (90 D):	$.89M
Avg Closing Volume:	344.53K

News

Oct 31, 2025 @ 7:15 AM Genomics Data Analysis Market Size to Surpass USD ... Source: Nova One Advisor

Aug 6, 2025 @ 1:00 PM PacBio to Present at Upcoming Investor Conferences... Source: Pacbio

Jun 21, 2025 @ 12:00 PM Long Read Sequencing Market Projected to Reach USD... Source: Sns Insider

May 14, 2025 @ 8:30 AM Metagenomics Market Size, Share, Forecast & Trends... Source: Researchandmarkets.Com

May 12, 2025 @ 2:56 PM PacBio Board Independent Investigation Concludes A... Source: N/A

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-1.69	$-.13	$-.14
Diluted EPS	$-2.15	$-.13	$-.14
Revenue	$154.58M	$38.44M	$39.77M
Gross Profit	$39.27M	$15.9M	$14.68M
Net Income / Loss	$-503.63M	$-38M	$-41.93M
Operating Income / Loss	$-665.69M	$-38.88M	$-44.85M
Cost of Revenue	$115.31M	$22.54M	$25.08M
Net Cash Flow	$-21.91M	$1.66M	$-4.09M
PE Ratio